Surgery Partners Posts 4.5% Revenue Growth

By Chris Stiles • Tuesday, May 05 14:27 • Permanent Link

Surgery Partners reported first-quarter 2026 revenue of $810.9 million, up 4.5% from $776.0 million a year earlier.

Same-facility revenue rose 4.4%, driven by a 3.8% increase in revenue per case and a 0.6% increase in same-facility cases.

Adjusted EBITDA came in at $102.3 million, down from $103.9 million in the first quarter of 2025.

The company posted a net loss attributable to Surgery Partners of $35.9 million for the quarter.

Operating cash flow improved to $11.7 million from $6.0 million in the prior-year quarter.

As of March 31, 2026, Surgery Partners had $182.3 million in cash and cash equivalents and $666.1 million of borrowing capacity under its revolving credit facility.

Total net debt to EBITDA was about 4.3x at quarter-end.

For 2026, the company reaffirmed revenue guidance of $3.35 billion to $3.45 billion and adjusted EBITDA of at least $530 million. Today the company's shares have moved 0.7% to a price of $14.30. For the full picture, make sure to review Surgery's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.